National consensus on management patients with endometriosis

В. М. Запорожан, Т. Ф. Татарчук, В. В. Камінський

Abstract


The National consensus on management patients with endometriosis includes the main issues of epidemiology, clinical manifestations, and diagnostics of this disease. The document also contained evidence-based recommendations on treatment tactics of endometriosis (medical and surgical treatment), secondary prevention of endometriosis.


Keywords


consensus; endometriosis; endometrial heterotopia; estrogens

References


SOGC Clinical practice guideline: diagnosis and management of endometriosis. JOGC, 2010.

Sinaii, N., et al. “Differences in characteristics among 1.000 women with endometriosis based on extent of disease.” Fertil Steril, 89(3) (2008): 538–545.

Guideline of the European Society of Human Reproduction and Embryology. Management of endometriosis, 2013.

M ol, B.W., Bayram, N., Lijmer, J.G., Wiegerinck, M.A., et al. “The performance of CA -125 measurement in the detection of endometriosis: a meta-analysis.” Fertil Steril, 70(1998): 1101–1108.

C onsensus on current management of endometriosis. Hum Reprod, 28(6) (2013): 1552–1568.

M ueck, A.O. “Dienogest: an oral progestogen for the treatment of endometriosis.” Expert Review of Obstetrics & Gynecology, 1 (Vol. 6) (2011): 5–15.

Köhler, G., Faustmann, T.A., Gerlinger, C., Seitz, C., Mueck, A.O. “A dose-ranging study to determine the efficacy and safety of 1, 2 and 4 mg of dienogest daily for endometriosis.” Int J Gynecol Obstet, 108(2010): 21–25.

Strowitzki, T., Marr, J., Gerlinger, C., Faustmann, T., Seitz, C. “Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial.” Hum Reprod, 25(2010): 633–634.

Harada, T., Momoeda, M., Taketani, Y., Aso, T., et al. “Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis – a randomized, double-blind, multicenter, controlled trial.” Fertil Steril, 91(3) (2009): 675–681.

C osson, M., Querleu, D., Donnez, J., Madelenat, P., et al. “Dienogest is as effective astriptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study.” Fertil Steril, 77(2002): 684–692.

Schindler, A.E. “Dienogest in long-term treatment of endometriosis.” Int J Womens Health, 3(2011): 175–184.

Schlaff, W.D., Carson, S.A., Luciano, A., Ross, D., Bergqvist, A. “Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain.” Fertil Steril, 85(2006): 314–325.

C rosignani, P.G., Luciano, A., Ray, A., Bergqvist, A. “Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain.” Hum Reprod, 21(2006): 248–256.

P etta, C.A., Ferriani, R.A., Abrao, M.S., Hassan, D., et al. “Randomized clinical trial of a levonorgestrel -releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis.” Hum Reprod, 20(2005): 1993.

Vercellini, P., Aimi, G., Panazza, S., et al. “A levonorgestrel – releasing intrauterine system for the treatment of dysmenorrhea associated with endometriosis: a pilot study.” Fertil Steril, 72(1999): 505–508.

Fedele, L., Bianchi, S., Zanconato, G., Portuese, A., Raffaelli, R. “Use of a levonorgestrel -releasing intrauterine device in the treatment of rectovaginal endometriosis.” Fertil Steril, 75(2001): 485–488.

W ong, C., et al. “Oral contraceptive pill as treatment for primary dysmenorrhoea.” Cochrane Database Syst Rev (2009).

Yap, C. “Pre and post operative medical therapy for endometriosis surgery.” Cochrane Database Syst Rev, 3(2004): CD003678.


GOST Style Citations


1. SOGC Clinical practice guideline: diagnosis and management of endometriosis. JOGC, 2010.

2. Sinaii, N., et al. “Differences in characteristics among 1.000 women with endometriosis based on extent of disease.” Fertil Steril, 89(3) (2008): 538–545.

3. Guideline of the European Society of Human Reproduction and Embryology. Management of endometriosis, 2013.

4. M ol, B.W., Bayram, N., Lijmer, J.G., Wiegerinck, M.A., et al. “The performance of CA -125 measurement in the detection of endometriosis: a meta-analysis.” Fertil Steril, 70(1998): 1101–1108.

5. C onsensus on current management of endometriosis. Hum Reprod, 28(6) (2013): 1552–1568.

6. M ueck, A.O. “Dienogest: an oral progestogen for the treatment of endometriosis.” Expert Review of Obstetrics & Gynecology, 1 (Vol. 6) (2011): 5–15.

7. Köhler, G., Faustmann, T.A., Gerlinger, C., Seitz, C., Mueck, A.O. “A dose-ranging study to determine the efficacy and safety of 1, 2 and 4 mg of dienogest daily for endometriosis.” Int J Gynecol Obstet, 108(2010): 21–25.

8. Strowitzki, T., Marr, J., Gerlinger, C., Faustmann, T., Seitz, C. “Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial.” Hum Reprod, 25(2010): 633–634.

9. Harada, T., Momoeda, M., Taketani, Y., Aso, T., et al. “Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis – a randomized, double-blind, multicenter, controlled trial.” Fertil Steril, 91(3) (2009): 675–681.

10. C osson, M., Querleu, D., Donnez, J., Madelenat, P., et al. “Dienogest is as effective astriptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study.” Fertil Steril, 77(2002): 684–692.

11. Schindler, A.E. “Dienogest in long-term treatment of endometriosis.” Int J Womens Health, 3(2011): 175–184.

12. Schlaff, W.D., Carson, S.A., Luciano, A., Ross, D., Bergqvist, A. “Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain.” Fertil Steril, 85(2006): 314–325.

13. C rosignani, P.G., Luciano, A., Ray, A., Bergqvist, A. “Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain.” Hum Reprod, 21(2006): 248–256.

14. P etta, C.A., Ferriani, R.A., Abrao, M.S., Hassan, D., et al. “Randomized clinical trial of a levonorgestrel -releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis.” Hum Reprod, 20(2005): 1993.

15. Vercellini, P., Aimi, G., Panazza, S., et al. “A levonorgestrel – releasing intrauterine system for the treatment of dysmenorrhea associated with endometriosis: a pilot study.” Fertil Steril, 72(1999): 505–508.

16. Fedele, L., Bianchi, S., Zanconato, G., Portuese, A., Raffaelli, R. “Use of a levonorgestrel -releasing intrauterine device in the treatment of rectovaginal endometriosis.” Fertil Steril, 75(2001): 485–488.

17. W ong, C., et al. “Oral contraceptive pill as treatment for primary dysmenorrhoea.” Cochrane Database Syst Rev (2009).

18. Yap, C. “Pre and post operative medical therapy for endometriosis surgery.” Cochrane Database Syst Rev, 3(2004): CD003678.





DOI: http://dx.doi.org/10.18370/2309-4117.2015.24.7-12

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

ISSN 2411-1295 (Online), ISSN 2309-4117 (Print)